(Q30371445)

English

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination. (English)

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

Javier Diez-Domingo

1

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

12

object named as

Paul Gillard

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

author name string

José-María Baldó

2

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Maria Victoria Planelles-Catarino

3

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

María Garcés-Sánchez

4

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Isabel Ubeda

5

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Angels Jubert-Rosich

6

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Josep Marès

7

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Pilar Garcia-Corbeira

8

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Philippe Moris

9

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Maurice Teko

10

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Carline Vanden Abeele

11

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

publication date

5 February 2015

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Influenza and Other Respiratory Viruses

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

9

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

68-77

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Influenza and the challenge for immunology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Immunofluorescence analysis of T-cell responses in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4353319

3 June 2018

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://api.crossref.org/works/10.1111%2FIRV.12295

21 January 2018

Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/IRV.12295

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30371445&oldid=1550051327"